quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:30:00·862d
PRRelease
AllianceBernstein Holding L.P. logo
Eyegate Pharmaceuticals, Inc. logo

AllianceBernstein Launches Five New Active ETFs

AB· AllianceBernstein Holding L.P.EYEG· Eyegate Pharmaceuticals, Inc.
FinanceHealth Care
Original source

Companies

  • AB
    AllianceBernstein Holding L.P.
    Finance
  • EYEG
    Eyegate Pharmaceuticals, Inc.
    Health Care

Recent analyst ratings

  • Jun 27ABUpdateGoldman$40.00
  • Apr 3ABUpdateBofA Securities$38.00
  • Feb 25ABUpdateTD Cowen$38.50
  • Aug 27ABUpdateBarclays$35.00
  • Jan 4ABUpdateTD Cowen$36.00
  • Oct 3ABUpdateGoldman$36.75

Related

  • SEC10d
    AllianceBernstein Holding L.P. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR10d
    AB Announces March 31, 2026 Assets Under Management
  • PR17d
    AB to Report First Quarter 2026 Results on April 28, 2026
  • PR23d
    Bernstein Private Wealth Management Appoints Kim Mustin to Lead Fast-Growing Business Owner Segment
  • PR43d
    AB Announces February 28, 2026 Assets Under Management
  • INSIDER63d
    CEO Bernstein Seth P sold $1,102,587 worth of AB Holding Units (26,840 units at $41.08), decreasing direct ownership by 10% to 241,046 units (SEC Form 4)
  • PR65d
    AllianceBernstein selects SimCorp One technology platform for investment teams
  • SEC70d
    SEC Form 10-K filed by AllianceBernstein Holding L.P.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022